Mechanism of Chinese herbal medicine delaying progression of chronic kidney disease

Zhongguo Zhongyao Zazhi

Volumn 34, Issue 8, 2009, Pages 939-943

  Dou, Chenhui ^a   Wan, Yigang ^b   Sun, Wei ^c   Zhagn, Huilang ^a   Chen, Jing ^a   Shui, Guangxing ^a   Yao, Jian ^d  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^c AFFILIATED HOSPITAL OF NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^d UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Chinese herbal medicine; Chronic kidney disease (CKD)

Indexed keywords

HERBACEOUS AGENT;

CELL TRANSDIFFERENTIATION; CHINESE MEDICINE; CHRONIC KIDNEY DISEASE; DIAPHRAGM INJURY; DISEASE COURSE; FIBROSING ALVEOLITIS; GLOMERULOSCLEROSIS; HERBAL MEDICINE; HUMAN; HYPERACTIVITY; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY FIBROSIS; MYOFIBROBLAST; NEPHROSCLEROSIS; PODOCYTE; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

CHRONIC DISEASE; DRUGS, CHINESE HERBAL; HUMANS; KIDNEY DISEASES; RENIN-ANGIOTENSIN SYSTEM; TRANSFORMING GROWTH FACTOR BETA;

EID: 67650526857     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney diseases: Evaluation, classification, and stratification[J]. Am J Kidney Dis, 2002,39(1/2):S1.
2. Agnes B, Fogo. Mechanisms of progression of chronic kidney disease[J]. Pediatr nephrol, 2007,22:2011.
3. Shankland S J. The podocyte's response to injury: Role in proteinuria and glomerulosclerosis[J]. Kidney Int, 2006,69:2131.
4. Fogo A B. Progression and potential regression of glomerulosclerosis[J]. Kidney Int, 2001,59:804.
5. Patrakka J, Tryggvason K. Nephrin-a unique structural and signaling protein of the kidney filter [J]. TRENDS Molecul Med, 2007,13:396. (Pubitemid 47385379)
6. Palmer B F. Proteinuria as a therapeutic target in patients with chronic kidney disease[J]. Am J Nephrol, 2007,27:287.
7. Burton C, Harris K P. The role of proteinuria in the progression of chronic renal failure1 [J]. Am J Kidney Dis, 1996,27:765. (Pubitemid 26169027)
8. Arovin B H, Tan L C. LDL stimulates messangial fibronectin production and chemoattractant expression [J]. Kidney Int, 1993,43:218.
9. Burton C J, Harper S J, Bailey E. et al. Turnover of human tubular cells exposed to proteins in vivo and in vitro [J]. Kidney Int, 2001,59:5. (Pubitemid 32157916)
10. Abbate M, Zoja C, Corna D, et al. In progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation [J]. J Am Soc Nephrol, 1998,9:1213.
11. Wolf G, Neilson E G. From converting enzyme inhibition to angiotensin II receptor blockade: New insights on angio-tensin II receptor subtypes in the kidney[J]. Exp Nephrol, 1996,4(Suppl 1):8. (Pubitemid 26421851)
12. Chen Tsohsiao, Wang Jinfong, Paul Chan, et al. Angiotensin II stimulates hypoxia-inducible factor1α accumulation in glomerular mesangial cells[J]. Ann N Y Acad Sci, 2005,1042:286.
13. Wenzel U. Aldosterone and progression of renal disease[J]. Curr Opin Nephrol Hypertens, 2008,17:44.
14. Tomohisa H, Hirofumi M, Hiroki N, et al. Effects of saireito, a Japanese herbal medicine, on edema via antagonistic actions against aldosterone in anti-GBM nephritic rats [J]. Clin Exp Nephrol, 2006,10:13.
15. Douthwaite J A, Johnson T S, Haylor JL, et al. Effects of transforming growth factor-beta1 on renal extracellular matrix components and their regulating proteins [J]. J Am Soc Nephrol, 1999,10:2109. (Pubitemid 29453488)
16. Huang Y, Noble N. An unexpected role of plasminogen activator inhibitot type-1 (PAI-1) in renal fibrosis [J]. Kidney Int, 2005,67:2502. (Pubitemid 41623417)
17. Yokoi H, Mukoyama M, Sugawara A, et al. Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis[J]. Am J Physiol Renal Physiol, 2002,282:F933. (Pubitemid 34654499)
18. Schrijjvers B F, Flyvbjerg A, De Vriese A S. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology [J]. Kidney Int, 2004,65:2003. (Pubitemid 38669987)
19. Kelly D J, Hepper C, Wu L L, et al. Vascular endothelial growth factor expression and glomerular endothelial cell loss in the remnant kidney model[J]. Nephrol Dial Transplant, 2003,18:1286. (Pubitemid 36826947)
20. Iwano M, Neilson E G. Mechanisms of tubulointerstitial fibrosis [J]. Curr Opin Nephrol Hypertens, 2004,13:279.
21. Lee H S, Kruth H S. Accumulation of cholesterol in the lesions of focal segmental glomerulosclerosis[J]. Nephrology (Carlton), 2003,8:224.
22. Ruan X Z, Varghese Z, Moorhead J F. Inflammation modifies lipid-mediated renal injury[J]. Nephrol Dial Transplant, 2003,18:27.
23. Andersen M J, Agarwa R. Etiology and management of hypertension in chronic kidney disease[J]. Med Clin North Am, 2005,89:525.